Indonesia remains growth market for Pharmaniaga


Pharmaniaga group managing director Datuk Zulkarnain Md Eusope

PETALING JAYA: Pharmaniaga Bhd expects to drive sales through its focus on growth opportunities in Indonesia and the private market in Malaysia while awaiting for the extension of its logistics and distribution agreement with the Health Ministry.

The logistic and distribution agreement is targeted to be executed in the fourth quarter of 2022, the pharmaceutical company said in a filing with Bursa Malaysia yesterday.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 48
Cxense type: NA
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!
   

Next In Business News

Kenanga Research urges investors to seek refuge in domestically-driven sectors
Perodua surpasses 250,000-unit mark, beats 2022 sales target
Asian shares tentative ahead of U.S. payrolls data, dollar nurses losses
U.S. Fed policy now more hawkish than policy rules suggest is needed
Ringgit opens higher vs US dollar for third day running
Quick take: Ranhill slips despite RM50mil contract win
FBM KLCI slips in early trade on profit taking
Trading ideas: AMMB, QL Resources, KNM, Sime Darby Plantation, Ireka, KPS, Ranhill Utilities
US economy grew slightly, inflation and rates cloud outlook
Wall St preps for year-end stock rally

Others Also Read